glp 1 receptor agonists incretin mimetics Clinical Focus on GLP-1 in Type 2 Diabetes Mellitus Introduction to Diabetes Type 1
Description
Diabetes Care 37, 21592167
Peng S, Xu J, Ruan W, Li S, Xiao F
In 2017, a multicenter study of 313 sites showed that only 6% of patients who were eligible to receive GLP-1 agonists were given this class of medication [126]
J Biol Chem 263: 1347513478, 1988
Abstract 277
